One data layer. Two verticals. No separation.
Capital markets infrastructure and health data integration are built on a shared foundation — engineered together from inception, not assembled after the fact.
Cross-border analytics for Asia-Pacific markets
Regulatory-native flow analytics built for APAC's multi-jurisdiction environment. Real-time cross-border capital tracking with full audit trails — no black boxes.
Institutional-grade tooling calibrated to SFC, MAS, and CSRC compliance frameworks. Data-native architecture means every position, every flow, every counterparty is traceable.
Preventive health data as portfolio intelligence
Structured health data feeds that translate biomedical signals into portfolio-relevant inputs — the integration that no legacy platform has operationalized.
Precision over velocity. Every health data signal is validated, normalized, and mapped to regulated reporting standards before it enters any decision layer.
Two verticals. One regulated data layer.
Fintech and biotech pipelines share a single ingestion and governance layer — so capital decisions and health signals are auditable, traceable, and portable across jurisdictions.